Ralmitaront — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRA2A ADRA2B ADRA2C ADRB1 ADRB2 ADRB3 CALCRL CHRM1 CHRM2 CHRM3 F2R MAOA MAOB MAP2K1 MAP2K2 NTRK1 NTRK2 NTRK3 OPRD1 OPRK1 OPRM1 P2RY12 PKLR SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SLC18A2 SLC6A2 SLC6A3 TLR7 TLR9 TUBA1A TUBA1B TUBA1C TUBA3C TUBA3E TUBA4A TUBB TUBB1 TUBB2A TUBB2B TUBB3 TUBB4A TUBB4B TUBB6 TUBB8 dacA dacB dacC folA ftsI mrcA mrcB mrdA pol rplA rplB rplC rplD rplE rplF rplI rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmB1 rpmB2 rpmC rpmD rpmE rpmE2 rpmF rpmG rpmG1 rpmG2 rpmH rpmI rpmJ rpmJ2 rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsR1 rpsR2 rpsS rpsT rpsU rpsZ ykgM ykgO

The experimentally established mechanism targets of Ralmitaront. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

	gene	UniProt	supporting neighbours	confidence
▸	SLC6A3 known ✓	Q01959	3/20	0.93

▸	TAAR1	Q96RJ0	5/20	0.93

▸	KCNH2	Q12809	2/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Ralmitaront SCHEMBL19356836	0.96	TAAR1 (1.00)	TAAR1SLC6A3KCNH2
Ralmitaront SCHEMBL19382698	0.96	TAAR1 (1.00)	TAAR1SLC6A3KCNH2
Ralmitaront SCHEMBL19356815	0.96	TAAR1 (1.00)	TAAR1SLC6A3KCNH2
Ralmitaront SCHEMBL29042164	0.95	TAAR1 (0.98)	TAAR1SLC6A3KCNH2
Ralmitaront SCHEMBL29042182	0.94	TAAR1 (0.94)	TAAR1SLC6A3KCNH2
Ralmitaront SCHEMBL29042181	0.92	TAAR1 (0.82)	TAAR1SLC6A3KCNH2
SCHEMBL28835606	0.86	TAAR1 (0.80)	TAAR1SLC6A3KCNH2
SCHEMBL28835621	0.86	TAAR1 (0.80)	TAAR1SLC6A3
SCHEMBL28835605	0.86	TAAR1 (0.80)	TAAR1SLC6A3KCNH2
SCHEMBL28835711	0.86	TAAR1 (0.80)	TAAR1SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4121428-B1	SALTS AND CRYSTALLINE FORMS OF A TAAR1 AGONIST	HOFFMANN LA ROCHE (CH)	2025-08-13	—	—	EP	disclosed
US-20230120311-A1	SALTS AND CRYSTALLINE FORMS OF A TAAR1 AGONIST	HOFFMANN-LA ROCHE INC. (US)	2023-04-20	—	—	US	disclosed
CN-115279752-A	Salts and crystalline forms of TAAR1 agonists	豪夫迈·罗氏有限公司	2022-11-01	—	—	CN	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20230120311-A1	SALTS AND CRYSTALLINE FORMS OF A TAAR1 AGONIST	TAAR1, TAAR5, MCHR1	SLC6A3 119/4885TAAR1 1/4885KCNH2 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.